CONSOLIDATED INCOME STATEMENT - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Net service revenue	$ 552,968	$ 557,890	$ 1,109,357	$ 1,103,147
Cost of service, inclusive of depreciation	297,455	316,211	612,465	621,031
General and administrative expenses:
Salaries and benefits	125,504	127,758	251,843	251,238
Non-cash compensation	9,108	5,148	12,381	12,495
Depreciation and amortization	4,725	6,220	9,168	14,228
Other	78,381	54,912	143,326	108,552
Total operating expenses	515,173	510,249	1,029,183	1,007,544
Operating income	37,795	47,641	80,174	95,603
Other income (expense):
Interest income	742	36	1,148	49
Interest expense	(7,502)	(8,311)	(15,019)	(11,484)
Equity in earnings (loss) from equity method investments	7,991	659	8,114	(744)
Merger termination fee	(106,000)	0	(106,000)	0
Miscellaneous, net	4,743	331	4,061	664
Total other expense, net	(100,026)	(7,285)	(107,696)	(11,515)
(Loss) income before income taxes	(62,231)	40,356	(27,522)	84,088
Income tax expense	(18,250)	(11,319)	(28,050)	(23,338)
Net (loss) income	(80,481)	29,037	(55,572)	60,750
Net loss attributable to noncontrolling interests	206	542	543	500
Net (loss) income attributable to Amedisys, Inc.	$ (80,275)	$ 29,579	$ (55,029)	$ 61,250
Basic earnings per common share:
Net (loss) income attributable to Amedisys, Inc. common stockholders	$ (2.46)	$ 0.91	$ (1.69)	$ 1.88
Weighted average shares outstanding, basic (shares)	32,579	32,522	32,568	32,538
Diluted earnings per common share:
Net (loss) income attributable to Amedisys, Inc. common stockholders	$ (2.46)	$ 0.91	$ (1.69)	$ 1.87
Weighted average shares outstanding, diluted (shares)	32,579	32,681	32,568	32,722